The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results of a phase Ib dose-escalation study of PRI-724, a CBP/beta-catenin modulator, plus gemcitabine (GEM) in patients with advanced pancreatic adenocarcinoma (APC) as second-line therapy after FOLFIRINOX or FOLFOX.
 
Andrew H. Ko
Consulting or Advisory Role - ARMO Biosciences; Celgene; Incyte; Merrimack; Oncogenex; Threshold Pharmaceuticals
Research Funding - Aduro Biotech (Inst); Celgene (Inst); ImClone Systems (Inst); Infinity Pharmaceuticals (Inst); PharmaEngine (Inst); PRISM BioLab (Inst); Seagen (Inst)
 
E. Gabriela Chiorean
Consulting or Advisory Role - Celgene; Genentech; Merrimack; Pfizer
Research Funding - Bristol-Myers Squibb; Celgene; Genentech; Incyte; PRISM Pharma; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Celgene; Celgene
 
Eunice Lee Kwak
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Paul I. Nadler
Employment - Nadler Pharma Associates
 
Debra L. Wood
Employment - Nadler Pharma Associates
 
Masamoto Fujimori
Employment - PRISM Pharma
Leadership - PRISM Pharma
Stock and Other Ownership Interests - PRISM Pharma
 
Tetsuhi Inada
Employment - PRISM Pharma
Leadership - PRISM Pharma
Stock and Other Ownership Interests - PRISM Pharma
 
Hiroyuki Kouji
Employment - PRISM Pharma
Leadership - PRISM Pharma
Stock and Other Ownership Interests - PRISM Pharma
 
Robert R. McWilliams
Research Funding - Aduro Biotech (Inst); Genentech (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); PRISM BioLab (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca